Company IPI Legacy Liquidation Co

Equities

Inactive Instrument

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

Delayed OTC Markets Other stock markets 02:08:57 2024-04-05 pm EDT			5-day change	1st Jan Change
0.015 ^USD	0.00%		0.00%	-87.85%

Apr. 12	North American Morning Briefing : Big Banks Kick -2-	DJ
Apr. 05	North American Morning Briefing : Investors on -2-	DJ

IPI Legacy Liquidation Co, formerly Impel Pharmaceuticals Inc., is not engaged in any business operations. The Company doesnât hold any assets.

Number of employees: 160

Managers	Title	Age	Since
John D. Hoekman FOU	Founder	43	07-12-31
Sheena Aurora CTO	Chief Tech/Sci/R&D Officer	-	-
Scott Youmans CTO	Chief Tech/Sci/R&D Officer	57	-
Sarah Wille HRO	Human Resources Officer	-	18-12-31
Lynn Gold LAW	General Counsel	67	18-06-30

Members of the board	Title	Age	Since
Timothy Nelson BRD	Director/Board Member	60	17-01-31
Ali Satvat BRD	Director/Board Member	46	18-12-06
Diane Wilfong BRD	Director/Board Member	62	19-09-16
David Allison BRD	Director/Board Member	42	19-05-31
John D. Hoekman FOU	Founder	43	07-12-31
Darren Cline BRD	Director/Board Member	59	23-04-11

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	23,900,031	21,120,240 ( 88.37 %)	0	88.37 %

Impel Pharmaceuticals, Inc.

201 Elliott Avenue West Suite 260

98119, Seattle

+206 568 1466

	1st Jan change	Capi.
IQVIA HOLDINGS INC.	-1.82%	41.35B
LONZA GROUP AG	+42.10%	40.38B
MODERNA, INC.	+2.56%	39.05B
CELLTRION, INC.	-12.11%	26.67B
ICON PUBLIC LIMITED COMPANY	+3.09%	24.07B
ALNYLAM PHARMACEUTICALS, INC.	-24.16%	18.36B
MEDPACE HOLDINGS, INC.	+22.12%	11.6B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.74%	11.68B
UNITED THERAPEUTICS CORPORATION	+7.75%	11.15B